Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP)
- PMID: 16753021
- DOI: 10.1359/jbmr.060215
Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP)
Abstract
FOP is a disabling disorder in which skeletal muscle is progressively replaced with bone. Lymphocytes, our model system for examining BMP signaling, cannot signal through the canonical Smad pathway unless exogenous Smad1 is supplied, providing a unique cell type in which the BMP-p38 MAPK pathway can be examined. FOP lymphocytes exhibit defects in the BMP-p38 MAPK pathway, suggesting that altered BMP signaling underlies ectopic bone formation in this disease.
Introduction: Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by progressive heterotopic ossification of connective tissues. Whereas the primary genetic defect in this condition is unknown, BMP4 mRNA and protein and BMP receptor type IA (BMPRIA) protein are overexpressed in cultured lymphocytes from FOP patients, supporting that altered BMP signaling is involved in this disease. In this study, we examined downstream signaling targets to study the BMP-Smad and BMP-p38 mitogen-activated protein kinase (MAPK) pathways in FOP.
Materials and methods: Protein phosphorylation was assayed by immunoblots, and p38 MAPK activity was measured by kinase assays. To examine BMP target genes, the mRNA expression of ID1, ID3, and MSX2 was determined by quantitative real-time PCR. Statistical analysis was performed using Student's t-test or ANOVA.
Results: FOP lymphocytes exhibited increased levels of p38 phosphorylation and p38 MAPK activity in response to BMP4 stimulation. Furthermore, in response to BMP4, FOP cells overexpressed the downstream signaling targets ID1 by 5-fold and ID3 by 3-fold compared with controls. ID1 and ID3 mRNA induction was specifically blocked with a p38 MAPK inhibitor, but not extracellular signal-related kinase (ERK) or c-Jun N-terminal kinase (JNK) inhibitors. MSX2, a known Smad pathway target gene, is not upregulated in control or FOP cells in response to BMP, suggesting that lymphocytes do not use this limb of the BMP pathway. However, introduction of Smad1 into lymphocytes made the cells competent to regulate MSX2 mRNA after BMP4 treatment.
Conclusions: Lymphocytes are a cell system that signals primarily through the BMP-p38 MAPK pathway rather than the BMP-Smad pathway in response to BMP4. The p38 MAPK pathway is dysregulated in FOP lymphocytes, which may play a role in the pathogenesis of FOP.
Similar articles
-
Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.J Bone Miner Res. 2005 Jul;20(7):1168-76. doi: 10.1359/JBMR.050305. Epub 2005 Mar 7. J Bone Miner Res. 2005. PMID: 15940369
-
Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.J Mol Cell Cardiol. 2006 Jul;41(1):26-33. doi: 10.1016/j.yjmcc.2006.03.421. Epub 2006 May 22. J Mol Cell Cardiol. 2006. PMID: 16716349
-
Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.Circ Res. 2008 May 23;102(10):1212-21. doi: 10.1161/CIRCRESAHA.108.173567. Epub 2008 Apr 24. Circ Res. 2008. PMID: 18436795
-
[BMP signaling and bone formation].Clin Calcium. 2012 Nov;22(11):1677-83. Clin Calcium. 2012. PMID: 23103811 Review. Japanese.
-
The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway.Biol Chem. 2013 Jun;394(6):703-14. doi: 10.1515/hsz-2012-0310. Biol Chem. 2013. PMID: 23324379 Review.
Cited by
-
Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.Genes (Basel). 2023 Nov 30;14(12):2162. doi: 10.3390/genes14122162. Genes (Basel). 2023. PMID: 38136984 Free PMC article. Review.
-
Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another?Wiley Interdiscip Rev Dev Biol. 2012 Jan-Feb;1(1):153-65. doi: 10.1002/wdev.9. Wiley Interdiscip Rev Dev Biol. 2012. PMID: 22408652 Free PMC article.
-
BMP type I receptor inhibition reduces heterotopic [corrected] ossification.Nat Med. 2008 Dec;14(12):1363-9. doi: 10.1038/nm.1888. Epub 2008 Nov 30. Nat Med. 2008. PMID: 19029982 Free PMC article.
-
From mysteries to medicines: drug development for fibrodysplasia ossificans progressive.Expert Opin Orphan Drugs. 2013 Aug;1(8):637-649. doi: 10.1517/21678707.2013.825208. Expert Opin Orphan Drugs. 2013. PMID: 24800180 Free PMC article.
-
Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions.Int J Mol Sci. 2020 Oct 14;21(20):7597. doi: 10.3390/ijms21207597. Int J Mol Sci. 2020. PMID: 33066607 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous